Alliance for Regenerative Medicine
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Alliance for Regenerative Medicine
Names of Lobbyists
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Fed Budget & Appropriations,
- Medical Research & Clin Labs,
- Science & Technology
Most Frequently Disclosed Bills
Bill No. Title H.R.1862 Regenerative Medicine Promotion Act of 2011 H.R.2112 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012 H.R.5651 Food and Drug Administration Reform Act of 2012 S.2375 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013 S.3187 Food and Drug Administration Safety and Innovation Act